ABT Stock Analysis: Buy, Sell, or Hold?
ABT - Abbott Laboratories
$95.40
3.22 (3.49%)
▲
5d:
+2.32%
30d:
+9.69%
90d:
-6.82%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 16, 2026
11d
Smart Money Accumulation
None View Scanner →
Strength: 8.0/10
Get Alerted When ABT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ABT shows positive signals but monitor for confirmation. Market pricing in 3.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ABT shows positive signals but monitor for confirmation. Market pricing in 3.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$151.13
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$93.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABT is currently trading at $95.40, which is considered extended relative to its 30-day fair value range of $87.11 to $92.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.8) compared to its historical average (17.6). Remarkably, the market is currently pricing in an annual earnings decline of 3.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ABT is in a strong downtrend. The price is approaching resistance at $95.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: ABT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $116.72 (+22.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABT is in a strong downtrend. The price is approaching resistance at $95.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: ABT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $116.72 (+22.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$87.11 -
$92.15
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 22.3% below Wall St target ($116.72)
Trading Range Analysis
30-Day Trading Range
$87.11 -
$92.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$87.21
Resistance Level
$95.74
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.75
Wall Street Target
$116.72
(+22.3%)
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-19.7%
Profit Margin
13.9%
Valuation Discount vs History
-3.6% cheaper
PE vs Historical
15.8 vs 17.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.6%
(market-implied from PE analysis)
1-Year Target
$91.97
(-4%)
2-Year Target
$88.65
(-7%)
3-Year Target
$85.46
(-10%)
3-Yr Target (if PE normalizes)
(PE: 16→18)
$95.52
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.5%)
$178.05
(+87%)
Base:
(SPY PE: 15.7, Growth: 10.5%)
$128.73
(+35%)
Bear:
(PE: 13.4, Growth: 10.5%)
$109.42
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 25.82 | Current EPS (TTM): $3.57
Bull Case
$172.07
(+80%)
Analyst growth 69.7%, PE expands to 28.4
Base Case
$156.42
(+64%)
Market implied 69.7%, PE stable at 25.8
Bear Case
$62.68
(-34%)
Severe decline -20.0%, PE contracts to 22.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.7 to 17.6
Stabilization Target:
$106.62
(+11.8%)
PE Expansion Potential:
+11.8%
Share & Embed Analysis
Last updated: July 03, 2026 9:08 PM ET
Data refreshes hourly during market hours. Next update: 10:08 PM
Data refreshes hourly during market hours. Next update: 10:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABT showing a specific setup today?
Insider Activity (6 Months)
7
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Laura Friedman
SELL
2026-03-24
Ro Khanna
BUY
2026-03-23
Featured in Portfolios
ABT is a key holding in these high-performance investment strategies.
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$80 | 65 BUY |
Advanced ABT Option Strategies
Professional options setups generated by AI based on today's ABT price and gamma walls.
